Saturday 7 November 2026
Export AHR’s income statement to Excel — free account
American Healthcare REIT, Inc.
AHR Real Estate Reit Healthcare Facilities
American Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 9.15% from fiscal 2024.
- Revenue
- +29.5%
- EPS
- −57.6%
- Free cash flow
- +9.53%
- Total debt
- −64.6%
Quarter to September 2026, against a year earlier
57.92
1.88
+3.35%
Follow AHR
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 6 Nov | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
114.78 | 81.31 | 76.69 | 104.61 |
P/S ratio |
3.46 | 3.73 | 4.02 | 4.16 | |
P/FCF ratio |
36.16 | 42.10 | 46.39 | 40.21 | |
P/Operating CF |
141.66 | 108.97 | 84.72 | 66.58 | |
P/B ratio |
2.33 | 2.51 | 2.69 | 1.99 | |
Price to Tangible BV |
2.72 | 2.91 | 3.07 | 2.23 | |
EV/Sales |
4.08 | 4.31 | 4.52 | 4.60 | |
EV/EBITDA |
23.69 | 24.67 | 25.67 | 27.93 | |
EV/Operating CF |
31.29 | 32.47 | 31.21 | 29.16 | |
EV/FCF |
42.64 | 48.72 | 52.16 | 44.50 | |
Quick Ratio |
0.41 | 0.45 | 0.48 | 0.53 | |
Current Ratio |
0.41 | 0.45 | 0.48 | 0.53 | |
Net Debt/EBITDA |
13.90 | 12.09 | 10.12 | 0.00 | |
Debt/Assets |
28.58% | 27.61% | 25.29% | 7.23% | |
Debt/Equity |
0.46 | 0.44 | 0.39 | 0.10 | |
Asset Turnover |
0.46 | 0.47 | 0.49 | 0.43 | |
Operating CF/Net income |
5.12 | 3.42 | 3.88 | 5.35 | |
Capex/Depreciation |
(0.69) | (0.50) | (0.50) | — | |
Interest Coverage |
1.86 | 2.25 | 2.32 | 2.64 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2.74% | 2.71% | 2.95% | 2.91% | |
Intangible Assets out of Total Assets |
0.09 | 0.09 | 0.08 | 0.08 | |
Share Based Compensation of Revenue |
0.90% | 0.75% | 0.86% | 1.25% | |
Graham Net Nets |
(0.22) | (0.19) | (0.15) | (0.14) | |
Graham Number |
13.66 | 15.66 | 17.24 | 16.85 | |
Earnings Yield |
0.87% | 1.23% | 1.30% | 0.96% | |
Free Cash Flow Yield |
2.77% | 2.38% | 2.16% | 2.49% | |
Revenue per Share |
3.64 | 3.47 | 3.50 | 3.42 | |
Operating CF per Share |
0.33 | 0.43 | 0.62 | 0.77 | |
Capex per Share |
(0.27) | (0.20) | (0.21) | 0.00 | |
Free Cash Flow per Share |
0.06 | 0.23 | 0.41 | 0.77 | |
Cash per Share |
0.91 | 0.84 | 0.99 | 1.19 | |
Shareholders Equity per Share |
20.24 | 18.80 | 19.42 | 25.75 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
20.24 | 18.80 | 19.42 | 25.75 | |
Free Cash Flow |
10.66 | 42.75 | 78.24 | 166.89 | |
Working Capital |
(511.44) | (491.60) | (460.76) | (434.87) | |
Capital Expenditures |
(44.50) | (38.32) | (40.38) | — | |
Net Current Asset Value |
(1,709.54) | (1,678.82) | (1,540.77) | (1,539.53) | |
EV/EBIT |
56.26 | 62.26 | 70.54 | 74.54 | |
Capex to Sales |
0.07 | 0.06 | 0.06 | 0.00 | |
Price to Operating Income |
47.72 | 53.80 | 62.73 | 67.36 | |
| Other line items | |||||
Average Receivables |
207.71 | 232.13 | 226.85 | 208.55 | |
Average Payables |
288.03 | 306.27 | 302.92 | 335.09 | |
Average Assets |
4,957.14 | 5,031.35 | 5,105.28 | 6,189.82 | |
Average Common Equity |
2,832.28 | 2,912.92 | 3,102.27 | 4,151.29 |
Columns are period end dates · fundamentals updated 6 Nov 2026